News & Views
Life Sciences Industry Raises the Bar in Northern Ireland
Jun 17 2019 Read 524 Times
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI) was unveiled at a BIO reception in Philadelphia hosted by the UK Department for International Trade, Invest Northern Ireland, the Welsh Government, BIA, AstraZeneca and the British American Business Council of Greater Philadelphia. A formal launch event followed on June 5 at the Union League of Philadelphia.
A partnership between academic, local government, clinical and life sciences constituencies, HIRANI is set to deliver the health and wealth potential of Northern Ireland’s thriving life sciences ecosystem, collectively promoting itself nationally and internationally, while driving connectivity across the sector and acting as a portal for external collaborators seeking to partner with the region.
Welcoming the news, ABPI Chief Executive Mike Thompson said:
“Northern Ireland has long punched well above its weight in terms of life sciences innovation, particularly in the fields of respiratory disease, heart disease and cancer. HIRANI will make it easier for its network of universities, industry and health organisations to work together to achieve improved health and social care outcomes for Northern Ireland’s 1.8 million residents, as well as sustained economic growth for the region.
“We look forward to playing an active role in partnering with HIRANI as we have in Greater Manchester, where a similar model has delivered 41 new life sciences collaborations over just two years.”
ABHI Chief Executive Peter Ellingworth commented: “We are delighted that HIRANI will provide the infrastructure to ensure that the life science community can work as a collective within Northern Ireland to then raise its profile internationally and play its leading role in global collaboration.”
BIA Chief Executive Steve Bates said: “By bringing together health care providers, research bodies, companies and supply chains, HIRANI will be ideally placed to identify and champion the exciting opportunities within the Northern Ireland life sciences ecosystem.
“This is further proof of the thriving life sciences sector in Northern Ireland and shows the diverse strength of the UK life sciences sector as a whole, where our global strength is underpinned by a world class research base and where innovative companies are working at the forefront of pioneering treatments for patients, across the nations of the UK.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - The Separation and Purification of Glutamine Deri...
View all digital editions
Nov 25 2019 Beijing, China
Dec 05 2019 New Delhi, India
Dec 13 2019 Kathmandu, Nepal
Jan 25 2020 San Diego, CA, USA
Jan 27 2020 Dubai, UAE